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ABSTRACT
Several recent publications have explored
cap-independent translation through an internal
ribosome entry site (IRES) in the 50-UTR of the
mRNA encoding the cyclin-dependent kinase
inhibitor p27. The major experimental tool used
in these reports was the use of bicistronic reporter
constructs in which the 50-UTR was inserted
between the upstream and downstream cistrons.
None of these reports has completely ruled out
the possibility that the 50-UTR has either cryptic
promoter activity or a cryptic splice acceptor site.
Either of these possibilities could result in expres-
sion of a monocistronic mRNA encoding the down-
stream cistron and false identification of an IRES.
Indeed, Liu et al. recently published data suggesting
that the p27 50-UTR harbors cryptic promoter
activity which accounts for its putative IRES activity.
In this report, we have explored this potential
problem further using promoterless bicistronic
constructs coupled with RNase protection assays,
siRNA knockdown of individual cistrons, RT-PCR to
detect mRNA encoded by the bicistronic reporter
with high sensitivity, direct transfection of bicistro-
nic mRNAs, and insertion of an iron response
element into the bicistronic reporter. The results
do not support the conclusion that the p27 50-UTR
has significant functional promoter activity or cryp-
tic splice sites, but rather that it is able to support
cap-independent initiation of translation.
INTRODUCTION
Translation of most eukaryotic cellular mRNAs is
initiated by the binding of the eIF4F complex to the
7-methylguanosine cap. This is followed by recruitment of
the 43S small ribosomal preinitiation complex and then
scanning of the complex to the start codon. An alternative
mechanism of translational initiation involves an internal
ribosome entry site (IRES). An IRES is an RNA element
that can facilitate ribosome recruitment independent of
the 50 cap structure of an mRNA. IRESs were ﬁrst
characterized in viral RNAs (1,2). Viral infection often
leads to inhibition of cellular mRNA translation by
inactivating the cap-dependent mechanism. For example,
polio virus infection leads to cleavage of eIF4G (3), an
essential component of the cap-binding eIF4F complex,
thereby inhibiting cap-dependent initiation. However, the
presence of an IRES in the viral RNA allows eﬃcient
synthesis of viral proteins to proceed under these
conditions.
A number of reports have described cellular mRNAs
with IRES activity (4). In many cases, these IRESs
are thought to allow continued translation under condi-
tions of cellular stress in which cap-dependent initiation
is repressed. The mechanisms by which translation is
initiated through IRESs in cellular mRNAs have not yet
been characterized in detail. Moreover, for many of
the putative cellular IRESs, it has been questioned
whether or not the analysis was stringent enough to
prove their existence (5). For example, it is common to use
a bicistronic vector system in which the putative IRES
sequence is inserted between the upstream and down-
stream coding regions. Expression of the downstream
cistron is indicative of an IRES encoded within the
inserted sequence. However, possible artifacts could
arise using this system if the insert has cryptic promoter
activity or a cryptic 30 splice site (5–7). In either case a
monocistronic mRNA encoding the downstream coding
region would be produced that would be translated in
a cap-dependent manner. It is clear that stringent tests
need to be performed in order to conclude that a cellular
mRNA has a functional IRES.
p27 is an inhibitor of cyclin-dependent kinases (CDKs)
and is best understood for its role in blocking the G1 to S
transition through inhibition of CDK2. Its expression
is often downregulated in tumor cells and for many types
of cancer there is a correlation between loss of p27
expression and poor prognosis (8). Conversely, p27 is
upregulated under conditions of growth factor deprivation
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involve enhanced translation of the p27 mRNA (9–12).
Therefore p27 translation is typically highest under
conditions where cap-dependent translation rates are
reduced. This suggested the possibility that the p27
mRNA contained an IRES that could mediate cap-
independent translation initiation. We tested this using a
variety of methods, including bicistronic vectors, strong
upstream stem-loops to block scanning and inhibition
of cap-dependent translation by active 4EBP (12). All of
the results supported the conclusion that an IRES resides
in the 50-UTR of the p27 mRNA. These results have been
independently veriﬁed by several other groups (13–15).
However, none of these reports completely ruled out the
possibility of a cryptic promoter or splice site residing
within the p27 50-UTR. In fact, a recent publication has
suggested that the p27 50-UTR does display cryptic
promoter activity and that this accounts for the putative
IRES activity (16). These authors used transfection of
promoterless constructs and RNase protection assays to
support their conclusions, which are clearly in disagree-
ment with previous reports supporting cap-independent
translation of the p27 mRNA. Given the conﬂicting
conclusions reached by this report and previous reports,
we have performed further experiments to examine the
possibility of cap-independent translation through the
p27 50-UTR. The results do not support the existence of
cryptic promoter activity or splice sites in the region,
indicating the presence of an authentic IRES capable of
mediating cap-independent initiation of translation.
MATERIALS AND METHODS
Constructionof plasmids
The dual luciferase bicistronic construct pTKLL was
constructed by ligating an XbaI/BglII fragment from
pRL-TK (Promega) with an AvrII/BglII fragment from
pGL2CAT. pTKLL-472, carrying the human p27 50-UTR
between the Renilla and ﬁreﬂy luciferase coding regions,
was constructed by ligating the XbaI/BglII fragment from
pRL-TK (Promega) with an AvrII/BglII fragment from
pGL2CAT/Luc-472 (17). To create the promoterless
bicistronic constructs, pLL and pLL-472, pTKLL and
pTKLL-472 were digested with MluI to remove the entire
TK promoter from the constructs. The digested plasmids
were then recircularized by ligation. To insert an IRE
into pTKLL-472, a two step PCR strategy was used. First,
two PCR reactions were performed using pTKLL-472 as
a template. One reaction used primers TKLL-IRE1
and TKLL-9-50 and the other reaction used primers
TKLL-IRE2 and TKLL-1080-30 (sequences available
upon request). The products of these reactions were
mixed as a template for the subsequent PCR ampliﬁcation
using primers TKLL-9-50 and TKLL-1080-30. The product
of this reaction was digested with NheI and ligated with
the large fragment resulting from NheI digestion of
pTKLL-472. The ﬁnal product (pTKLL-472-IRE) has
an IRE 35nt downstream of the transcriptional start site
of the TK promoter. Monocistronic constructs based
on the pGL4 backbone were prepared by ligating the
p27 50-UTR sequence, in either the forward or reverse
orientation, into the HindIII site of PGL4.10[luc2]
(Promega). Bicistronic constructs based on the pGL4
backbone were prepared by ﬁrst ligating the p27 50-UTR
sequence, in either the forward or reverse orientation,
into the HindIII site of pGL4.70[hRluc] creating
pGL4.70[hRluc]-472 and pGL4.70[hRluc]-472R. The
NheI/XbaI fragments from these two constructs were
then ligated into the XbaI site of pGL4.13[luc2/SV40]
creating pGL4.13-F/R-472 and pGL4.13-F/R-472R.
Promoterless bicistronic constructs, pGL4.10-F/R-472
and pGL4.10-F/R-472R, were prepared by ligating
the NheI/XbaI fragments from pGL4.70[hRluc]-472
and pGL4.70[hRluc]-472R into the XbaI site of
pGL4.10[luc2].
Cell culture, DNA transfections and reporter gene assays
Breast cancer cell lines were grown in Dulbecco’s modiﬁed
Eagle Medium (DMEM) containing 10% fetal calf serum,
100U/ml penicillin and 100mg/ml streptomycin. NIH3T3
cells were grown in the same medium but with newborn
calf serum. All cells were incubated in a humidiﬁed
atmosphere containing 5% CO2. DNA constructs were
transfected using GenePORTER (Gene Therapy Systems)
or Dreamfect (Boca Scientiﬁc) according to the manufac-
turers’ instructions. Renilla and ﬁreﬂy luciferase levels
were tested using the Dual-Glo
TM Luciferase assay system
(Promega). Where indicated, DFO was added to the
cultures at a ﬁnal concentration of 100mM.
In vitro transcription andmRNA transfection
DNA templates for in vitro transcription were made by
PCR using the Advantage 2 PCR kit (BD Biosciences).
Vectors containing the human p27 472nt 50-UTR inserted
in the forward and reverse orientations between the
Renilla and ﬁreﬂy coding regions were used as templates
for PCR. The 50 primer contained a T7 50 overhang
and the 30 primer contained a 30nt polyA 30 overhang.
The templates were gel puriﬁed after PCR.
Messenger RNA (G-capped, polyA-tailed) was made
in vitro using the mMessage Machine kit (Ambion) using
1mg of the gel-puriﬁed templates as per kit protocol.
The mRNA was checked on a formaldehyde gel and
the concentration calculated. The mRNA was then
transfected into the diﬀerent cell lines using DMRIE-C
transfection reagent (Invitrogen). Cells in 35mm dishes
were rinsed to remove any antibiotics. DMEM (1ml/dish)
was mixed with the DMRIE-C and then the RNA was
added at a ratio of 2ml DMRIE-C per 1mg RNA. The
mixture was vortexed and immediately applied to the cells.
After a 4h incubation at 378C with 5% CO2, the medium
was replaced with DMEM containing 10% FCS. The cells
were incubated six additional hours and then harvested
in 150ml1   Reporter Lysis Buﬀer (Promega).
RT-PCR
MCF7 cells were transfected with pTKLL or pTKLL-472
one day before harvesting. Cells were lysed in RLN buﬀer
containing 50mM Tris-HCl pH 8.0, 140mM NaCl,
1.5mM MgCl2, 0.5% NP-40, 1mM dithiothreitol and
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at  600 g for 10min and the supernatants were used
to extract RNA using the RNeasy Mini Kit (Qiagen).
To remove DNA contamination, RNA samples were
further treated with DNase and then DNase was inacti-
vated using TURBO DNA-free (Ambion). The isolated
RNA was then used as a template for reverse transcription
using AMV reverse transcriptase and a 30-speciﬁc primer
and ampliﬁed by PCR using speciﬁc primers. The PCR
product spans the entire Renilla luciferase coding region
and the ﬁrst 70bp of the ﬁreﬂy luciferase coding region
(see Figure 5).
RNase protection assays
DNA templates for preparing radioactive RNA probes
were prepared by PCR using the Advantage PCR system
(Clontech). The 50 primer for each reaction included a T7
promoter sequence. The regions ampliﬁed for each probe
are shown in Figure 2. The templates were gel puriﬁed by
agarose gel electrophoresis, ethanol precipitated, and then
redissolved in sterile water at a concentration of 0.5mg/ml.
Labeled probes were synthesized using the T7 Maxiscript
kit (Promega) by including 32P-UTP in the reaction.
Probes were puriﬁed by electrophoresis using denaturing
4% polyacrylamide gels. Probes were estimated to have
a speciﬁc activity of  5 10
8c.p.m./mg.
Total cellular RNA was isolated from transfected cells
using the RNeasy Mini kit (Qiagen). RNA samples were
treated with Turbo DNA-Free (Ambion) to remove any
traces of DNA. RNase protection assays were performed
using the RPA II kit (Ambion) following the manufac-
turer’s protocol. Protected fragments were separated by
electrophoresis on denaturing polyacrylamide gels and
bands were visualized by autoradiography.
RESULTS
Analysis ofapromoterless bicistronic construct containing
the sequence encodingthe p27 50-UTR
One of the most common methods of testing for
IRES activity is to use a bicistronic vector in which the
putative IRES is inserted between two protein coding
regions. We (12,17) and others (13–15) have used this
assay for analyzing the activity of the p27 50-UTR and
the results have supported the conclusion that this
region contains an IRES. Transfection of the bicistronic
construct into cells should result in the transcription of
a single mRNA that encodes both the upstream and
downstream cistrons. Transcription of this message is
dependent on the promoter sequence upstream of the ﬁrst
cistron. However, if the putative IRES harbors a sequence
that can function as a promoter, then a monocistronic
mRNA encoding only the downstream cistron will be
produced. Since the reporter gene encoded by the down-
stream cistron is monitored by a very sensitive assay, even
a low level of expression through a cryptic promoter in the
putative IRES-containing sequence will be detectable.
One way to test for cryptic promoter activity in
the putative IRES-containing sequence is to delete the
authentic promoter upstream of the ﬁrst cistron.
This should eliminate or greatly reduce expression of the
bicistronic message. Expression of both the upstream
cistron, which is translated in a cap-dependent manner
and the downstream cistron, which is translated in an
IRES-dependent manner, should be aﬀected. However,
if expression of the downstream cistron is dependent on
a cryptic promoter, then its expression should not be
aﬀected. Indeed, Liu et al. (16), based on the use of
promoterless bicistronic constructs together with RNase
protection assays, have concluded that the sequence
encoding the p27 50-UTR has promoter activity. This
conclusion is inconsistent with a substantial body of work
suggesting the presence of an IRES in the 50-UTR of the
p27 mRNA.
To further explore the possibility of cryptic promoter
activity, the sequence encoding the full-length p27 50-UTR
(18) was inserted into a bicistronic construct between an
upstream cistron encoding Renilla luciferase and a down-
stream cistron encoding ﬁreﬂy luciferase (Figure 1A).
Expression of this construct (pTKLL472) is driven by the
viral thymidine kinase (TK) promoter. A second construct
was prepared in which the TK promoter was deleted
(pLL472). Similar constructs lacking the p27 50-UTR
sequence were also prepared (pTKLL and pLL). These
constructs were transfected into the breast cancer cell line
MCF7 (Figure 1B). Deletion of the TK promoter resulted
in considerable loss of Renilla luciferase expression
(compare pTKLL to pLL and pTKLL472 to pLL472).
However, there was not a complete loss of activity, with
both promoterless constructs retaining 15–20% of the
activity of the upstream cistron relative to the construct
containing the TK promoter.
As expected, neither construct lacking the sequence
encoding the p27 50-UTR (pTKLL and pLL) had sub-
stantial levels of ﬁreﬂy luciferase expression. In agreement
with previous publications (12–15,17), the TK promoter-
driven construct containing the p27 50-UTR sequence
(pTKLL472) showed high-level expression of the down-
stream cistron. However, deletion of the TK promoter
resulted in only a  24% decrease in expression of ﬁreﬂy
luciferase. This indicates that a major portion of the
expression of the downstream cistron is dependent on
the p27 50-UTR but not on the TK promoter.
One possibility for the results above is that the p27
50-UTR has promoter activity resulting in production of
a monocistronic message encoding ﬁreﬂy luciferase.
To examine this possibility we performed RNase protec-
tion assays. Four diﬀerent probes, each complimentary
to a diﬀerent region of the mRNAs encoded by the
bicistronic constructs, were utilized (Figure 1A). Probe 1 is
180nt in length and protects a fragment of  100nt from
cells transfected with pTKLL (Figure 1C, lane 5) and
pTKLL472 (Figure 1C, lane 6). This corresponds to
the size expected if the TK promoter is used to initiate
transcription. A second major band of  130nt is also
detected in these lanes. This fragment could only result
from transcriptional initiation in the vector somewhere
upstream of the TK start site. Interestingly, there are
also protected fragments from cells transfected with the
promoterless constructs pLL (Figure 1C, lane 7) and
pLL472 (Figure 1C, lane 8). These bands indicate
Nucleic Acids Research, 2007, Vol. 35, No. 14 4769Figure 1. Transfection of bicistronic reporter constructs into MCF7 cells. (A) Diagram of constructs used in the transfections and probes used
for RNase protection assays. Construct names are indicated on the right. The p27 50-UTR is a 472nt sequence upstream of the p27 start codon.
It is inserted between the coding regions for Renilla luciferase (R-Luc) and ﬁreﬂy luciferase (FF-Luc). The region spanned by the in vitro synthesized
mRNA used as a control in RNase protection assays is shown at the bottom. (B) The bicistronic constructs were transfected into MCF7 human
breast cancer cells. One day after transfection, the cells were harvested and the activity of both Renilla luciferase (left) and ﬁreﬂy luciferase (right)
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upstream vector sequences, even in the absence of any
known promoter.
Probe 2 is 256nt in length and protects a fragment
of 227nt within the upstream cistron encoding Renilla
luciferase. This probe hybridizes with RNAs from cells
transfected with each of the bicistronic reporter
constructs, including those in which the TK promoter
has been deleted (Figue 1D, lanes 5–8). The intensity of
the protected band is similar in all four samples.
An identical band is observed in the control sample
using in vitro transcribed bicistronic RNA (IVT RNA,
lane 3), while no band is observed in the control lane using
RNA from untransfected cells (lane 4). In titration
experiments,  0.024fmol of the in vitro transcribed
RNA was easily detectable, indicating the high sensitivity
of this assay. The results again support the conclusion
that substantial transcription initiation occurs in vector
sequences independent of the TK promoter.
Probe 3 is 390nt in length and encompasses the 30 end
of the Renilla luciferase gene and 200nt of the p27
50-UTR. It protects a band of 166nt in cells transfected
with bicistronic constructs lacking the p27 50-UTR
(pTKLL or pLL, Figure 1E, lanes 5 and 7). A band of
approximately equal intensity is observed with both
constructs, indicating a signiﬁcant level of transcription
independent of the TK promoter. Probe 3 should protect
a fragment of 367nt from cells transfected with bicistronic
constructs carrying the p27 50-UTR and a band of this
size is detected both with (lane 6) and without (lane 8)
the TK promoter. However, two additional strong bands
of  210 and 125nt are detected in these samples.
Importantly, exactly the same pattern of bands is observed
in the control sample using in vitro transcribed RNA.
was determined. Black bars represent enzyme activity in the constructs carrying the TK promoter (pTKLL and pTKLL472) and gray bars represent
activity in the promoterless constructs (pLL and pLL472). RLU indicates relative light units. Error bars represent SD. (C) RNase protection assay
using Probe 1 (see panel A). Lane 1 is undigested probe. Lane 2 is probe treated with RNase. Lane 3 is probe hybridized with in vitro synthesized
mRNA. Lane 4 is probe hybridized with RNA isolated from untransfected cells. In lanes 5–8, probe was hybridized with RNA from cells transfected
with the constructs indicated at the top of each lane. Lane 9 is labeled marker RNAs of the size indicated on the right. The arrowhead indicates
a band of  100nt and is the size expected for accurate transcription initiation from the TK promoter. The asterisks mark major bands observed
after transfecting cells with constructs lacking the TK promoter. (D) RNase protection assay using Probe 2. Lanes are the same as described for C.
The arrowhead indicates a band of  227nt, which is the size expected if transcription is initiated at any point upstream of the probe sequence.
(E) RNase protection assay using Probe 3. Lanes are as describe for C. The arrowhead in lane 3 indicates a band of  367nt which is the expected
size for cells transfected with the constructs carrying the p27 50-UTR. The asterisks indicate bands of  210 and  125nt which are also observed in
lanes 6 and 8. The open arrowhead in lane 5 indicates a band of  166 which is the expected size for cells transfected with the constructs lacking
the p27 50-UTR. (F) RNase protection assay using Probe 4. Lanes are as described for C. Arrowhead in lane 3 indicates a band of  530nt and is the
major band observed for in vitro transcribed mRNA as well as in cells transfected with constructs carrying the p27 50-UTR. The open arrowhead in
lane 5 indicates a band of the expected size for cells transfected with constructs lacking the p27 50-UTR. (G) The RNase protection assay with Probe
4 was repeated using less in vitro synthesized mRNA (lane 4) in order to obtain bands of similar intensity to those observed using RNA from
cells transfected with constructs containing the p27 50-UTR (lanes 5 and 6).
Figure 1. Continued
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initiation at a cryptic promoter within this region and
are most likely to be the result of strong secondary
structures in the RNA.
Probe 4 is 632nt in length and spans the entire p27
50-UTR and the 50 end of the ﬁreﬂy luciferase coding
region. This probe is expected to protect a 95nt fragment
from cells transfected with the bicistronic reporters lacking
the p27 50-UTR. A band of approximately this size is
detected for both pTKLL and pLL (Figure 1F, lanes 5
and 7). For full-length transcripts from the bicistronic
constructs containing the p27 50-UTR, the probe should
protect a fragment of 584nt. For cells transfected
with either pTKLL472 or pLL472a faint band with
a calculated size of 588nt is observed along with two
stronger bands with calculated sizes of  531 and  494nt
and a series of minor bands of smaller size (Figure 1F,
lanes 6 and 8). The identical pattern of bands is observed
when in vitro transcribed bicistronic RNA is used for the
hybridization reaction (Figure 1F, lane 3 and Figure 1G,
lane 4). Thus, the observed bands cannot be the result
of alternative transcription initiation sites within the
sequence encoding the p27 50-UTR and there is no
evidence of signiﬁcant cryptic promoter activity within
this region.
The results presented above indicate that the reporter
constructs have signiﬁcant transcriptional activity that is
independent of the authentic TK promoter. Cryptic
transcriptional regulatory sequences and promoter
elements in vector sequences have been observed
previously and are a common problem in reporter
gene assays (19–23). In an attempt to minimize this
problem we generated a series of reporter constructs
base on the vector pGL4. This vector (Promega
Corporation) has been extensively modiﬁed to remove
cryptic regulatory sequences and promoter elements in
the vector backbone as well as in the luciferase coding
region (24). An upstream synthetic poly(A) signal/
transcription pause site was also incorporated to
impede read through from any transcripts initiated
in vector sequences. We prepared both monocistronic
and bicistronic reporters based on the pGL4 backbone.
For the monocistronic constructs, the p27 50-UTR was
cloned upstream of ﬁreﬂy luciferase either in the
forward or reverse orientation (Figure 2A). The forward
50-UTR construct expressed slightly higher luciferase
activity than either the reverse 50-UTR construct or the
parent vector (pGL4.10, Figure 2B). However, the
activity of the forward 50-UTR construct was expressed
at a level nearly 600-fold less than a similar construct
in which luciferase expression is driven by the SV40
promoter [pGL4.13(SV40)]. These results indicate that
the p27 50-UTR has minimal, if any, promoter activity
in this setting.
pGL4-based bicistronic constructs were prepared in
which the p27 50-UTR, either forward or reverse orienta-
tion, was cloned between the ﬁreﬂy luciferase (upstream
cistron) and Renilla luciferase (downstream cistron)
coding regions. Constructs with and without the SV40
promoter upstream of ﬁreﬂy luciferase were prepared
(Figure 3A). Expression of the upstream cistron was
almost entirely dependent on the presence of the
SV40 promoter regardless of the orientation of the p27
50-UTR (Figure 3B). For the downstream cistron, elevated
expression was only observed for the construct
carrying the SV40 promoter and the p27 50-UTR in the
forward orientation. There was some expression of
the downstream cistron in the construct carrying the p27
50-UTR in the absence of the promoter, but this was
only  15% of that observed with the promoter. With the
promoter-driven construct carrying the 50-UTR in the
reverse orientation the downstream cistron was expressed
at  6% of the level of same construct with the 50-UTR in
the forward orientation. Thus expression of the down-
stream cistron is dependent on the orientation of the p27
50-UTR and the presence of the SV40 promoter upstream
of the ﬁrst cistron.
Figure 2. Transfection of pGL4-based monocistronic vectors into
MCF7 cells. (A) Diagram of monocistronic constructs. (B) Fireﬂy
luciferase activity after transfection of each of the constructs as shown
in A. The number above each bar represents the mean of three separate
transfections (in RLU 10
 6). The error bars represent SD.
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and downstream cistrons of bicistronic RNAs
To further support the conclusion that both cistrons can
be expressed from a single mRNA molecule, bicistronic
vectors containing the p27 50-UTR were cotransfected
with siRNAs targeted to either the Renilla luciferase
sequence or the ﬁreﬂy luciferase sequence. Two diﬀerent
pGL4-based bicistronic vectors were used in these experi-
ments. One construct has the Renilla luciferase sequence
as the upstream cistron and the ﬁreﬂy luciferase sequence
as the downstream cistron (Figure 4A) while the other has
the ﬁreﬂy luciferase sequence upstream and the Renilla
luciferase sequence downstream (Figure 4B). With both
constructs, siRNAs targeting either of the luciferase genes
substantially reduced expression of both enzymes. It is
especially important to note that siRNA inhibition of
the upstream cistron also led to inhibition of the down-
stream cistron, further supporting the conclusion that
the p27 50-UTR mediates translation in a cap-independent
manner.
Transfectionof in vitrotranscribed bicistonic mRNAs
Another means of testing for IRES activity is to directly
transfect bicistonic mRNAs into cells. In this way, the
processes of transcription and RNA processing are
bypassed and there is no possibility of cryptic promoter
activity or cryptic splicing through the putative IRES
encoding region. Two bicistronic mRNAs were produced
by in vitro transcription (Figure 5, top). One mRNA
included the p27 50-UTR in the forward direction and
the other mRNA included the complement of the p27
50-UTR. Thus both mRNAs were of equal length and
the distance between the two protein coding regions was
identical. In addition, a 7-methylguanosine cap and a
polyA tail of 30nt was incorporated into both mRNAs.
The mRNAs were transfected into two diﬀerent breast
cancer cell lines (Figure 5, bottom). In both lines
expression of the downstream cistron (ﬁreﬂy luciferase)
was enhanced by the p27 50-UTR in the forward direction,
supporting the conclusion that this sequence is able to
promote cap-independent translation.
Figure 3. Transfection of pGL4-based bicistronic vectors into MCF7 cells. (A) Diagram of bicistronic constructs. (B) The left panel shows activity of
the upstream cistron (Fireﬂy luciferase) and the right panel shows activity of the downstream cistron (Renilla luciferase). Bars labeled 472 indicate
constructs with the p27 50-UTR in the forward orientation and bars labeled 472R indicate constructs with the p27 50-UTR in the reverse orientation.
For bars labeled  Promoter cells were transfected with constructs lacking a promoter upstream of the ﬁrst cistron and for bars labeled +Promoter
cells were transfected with constructs carrying the SV40 promoter. The number above each bar indicates the mean of three separate transfections.
The error bars represent SD.
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thebicistronic constructs
Using northern blotting, we (12) and others (13,14) have
previously characterized the transcripts produced by
transfecting cells with bicistronic constructs containing
the p27 50-UTR. These experiments did not reveal any
small transcripts that might have resulted from a cryptic
splice site in the 50-UTR. However, northern blotting
may not be sensitive enough to detect low levels of
short transcripts. Van Eden et al. (7) have utilized an
RT-PCR strategy for detecting transcripts produced from
bicistronic vectors. We have employed a similar procedure
using one primer from just downstream of the TK
promoter transcriptional start site and the other primer
from within the ﬁreﬂy luciferase coding region (Figure 6,
top). Using this primer pair should result in the
ampliﬁcation of a  1635bp fragment from the authentic
bicistronic message from the reporter construct carrying
the p27 50-UTR (pTKLL-472) and a  1160bp fragment
from the control construct lacking the UTR (pTKLL).
MCF7 cells were transfected with these bicistronic
reporter constructs. As a control, another culture was
left untransfected. Total RNA was isolated, and then RT-
PCR was performed (Figure 6, bottom). To control for
contaminating plasmid DNA, a separate reaction was
performed in which the reverse transcriptase was left out.
Figure 4. siRNA knockdown of luciferase expressed from bicistronic
constructs. (A) The pGL4-based bicistronic reporter shown at the top
of the diagram was cotransfected into MCF7 cells with a control
scrambled siRNA, an siRNA targeted to ﬁreﬂy luciferase (siFLuc), or
an siRNA targeted to Renilla luciferase (siRLuc). Fireﬂy and Renilla
luciferase activities were determined and are expressed as percent of the
control with the scrambled siRNA. The number above each bar
represents the relative luciferase activity (% of control). (B) Same as in
A except that ﬁreﬂy luciferase is the upstream cistron and Renilla
luciferase is the downstream cistron.
Figure 5. Transfection of bicistronic mRNAs into human breast cancer
cells. Top: Diagram of mRNA molecules that were synthesized by
in vitro transcription. The arrows indicate the direction of the p27
50-UTR sequence (reverse is the antisense orientation and forward is
the sense orientation). Bottom: The in vitro synthesized mRNAs
were transfected into two human breast cancer cell lines (MCF7 and
MDA-MB-231) and Renilla and ﬁreﬂy luciferase activities were
determined. For each cell line, the ratio of ﬁreﬂy to Renilla luciferase
activity is shown for the antisense 50-UTR (Reverse, gray bars) and
the sense 50-UTR (Forward, black bars).
4774 Nucleic Acids Research, 2007, Vol. 35, No. 14A major band of the expected size was observed only in
the lanes which included reverse transcriptase. Also,
slightly larger RT-PCR products, of unknown origin,
were observed for both the pTKLL and pTKLL-472
transfected cells. Importantly, in cells transfected with
the p27 50-UTR-containing construct, we did not detect
any ampliﬁcation products of a smaller size that were
also not detected in the untransfected cells and the
cells transfected with pTKLL. These results do not
support the existence of a cryptic splice site within
the 50-UTR.
Aniron-response element (IRE)inhibits expression
ofonly theupstream cistron
To further explore the possibility of cryptic splicing
sites within the p27 50-UTR we inserted an IRE 35nt
downstream of the transcriptional start site of the TK
promoter in pTKLL-472 (Figure 7, top). There is no
potential 50 splice site within this 35nt sequence. This, and
the proximity of the IRE to the transcriptional start site,
makes it extremely unlikely that any splicing event
would occur within this region. Thus any splicing event
involving a cryptic 30 splice site in the p27 50-UTR would
have to use a 50 splice site downstream of the IRE. This, in
eﬀect, would transfer the IRE to a position upstream of
the ﬁreﬂy luciferase coding region. If this occurred,
expression of ﬁreﬂy luciferase would become sensitive to
iron chelation, which leads to activation of iron-response
protein (IRP). Active IRP binds to IREs and blocks
cap-dependent translation.
The bicistronic construct containing the IRE, as well as
the control construct lacking the IRE, were transfected
into NIH3T3 cells (Figure 7, bottom). The cells were
treated with or without deferoxamine (DFO), a cell
permeable iron chelator, and then harvested for luciferase
assays. For the control construct lacking an IRE,
treatment with an iron chelator had no eﬀect on either
Renilla or ﬁreﬂy luciferase activity. In contrast, treatment
of cells transfected with the IRE-containing construct
caused  50% inhibition of Renilla luciferase expression
while having no eﬀect on ﬁreﬂy luciferase expression.
These data provide further support for the conclusion that
expression of the downstream cistron does not result from
the presence of cryptic splice acceptor site within the
p27 50-UTR.
DISCUSSION
Bicistronic reporter constructs are commonly used to
study cap-independent translation through IRESs.
However, this approach has been criticized because of
possible artifacts from cryptic promoter activity (5,6)
or a cryptic splicing site (5,7) residing within the test
sequence. At least ﬁve previous publications have
analyzed p27 50-UTR sequences using bicistronic vectors
and all have concluded that an IRES is present within
this region (12–15,17). However, these ﬁndings were
recently contradicted by the experiments of Liu et al.
(16). This group used promoterless bicistronic reporter
constructs to support the conclusion the p27 50-UTR has
an absence of IRES activity, but rather that the DNA
sequence encoding the p27 50-UTR has cryptic promoter
activity. This group further supported this conclusion
using RNase protection assays to detect putative
transcription start sites within the sequence encoding the
p27 50-UTR. In this report, we also used bicistronic
constructs with and without a promoter upstream of the
ﬁrst cistron. Like Liu et al. (16) we found that signiﬁcant
expression of the downstream cistron was retained even
after deletion of the TK promoter in the bicistronic
construct carrying the p27 50-UTR. However, our RNase
protection assays demonstrated that there is considerable
Figure 6. RT-PCR analysis of transcripts produced from bicistronic
reporter plasmids. Top: Diagram of the transcripts that should be
produced following transfection when transcription initiates from the
TK promoter of the bicistronic reporter construct lacking an insert
(pTKLL) and the construct carrying the p27 50-UTR (pTKLL-472).
Arrows below each diagram indicate the position of primers used for
RT-PCR analysis. RT-PCR should produce a DNA fragment of
 1635nt if there is no splicing due to a cryptic splice acceptor
site in the p27 50-UTR. The expected size for the fragment
from pTKLL transfected cells is  1160nt. Bottom: The bicistronic
reporters were transfected into MCF7 cells as indicated. The control
reactions (C) were from untransfected cells. RNA was isolated and
used for RT-PCR with the primer pair indicated in the diagram.
Reactions in which all conditions were identical except that reverse
transcriptase was omitted ( RT) were performed for each of the RNA
templates.
Nucleic Acids Research, 2007, Vol. 35, No. 14 4775transcriptional initiation within vector sequences that
is independent of the TK promoter. This vector-initiated
transcription would be expected to inhibit expression
of the upstream cistron because of numerous
upstream AUG start codons and stop codons. The
downstream cistron should still be actively expressed
through cap-independent translational initiation mediated
by the IRES. This is what was observed in our
experiments.
Another important observation of our experiments
is the detection of ‘extra’ bands in RNase protection
assays using probes complimentary to the p27 50-UTR.
These bands could be interpreted as being the result of
transcriptional initiation through cryptic promoters in
the 50-UTR sequence, as suggested by Liu et al. (16).
However, exactly the same pattern of bands was observed
when in vitro transcribed RNA was used in the RNase
protection assay. Thus, the bands cannot be due to
promoter activity in this region and are most likely
the result of very strong secondary structure in the p27
50-UTR. The ﬁndings highlight the importance of includ-
ing the in vitro transcribed RNA control when using
RNase protection assays to map potential transcription
initiation sites. This control was not included in the
experiments described by Liu et al. (16) and it is likely that
the putative transcription start sites in the p27 50-UTR
reported by this group are actually due to RNA secondary
structure rather than transcriptional initiation.
Our experiments indicate a signiﬁcant level of vector-
initiated TK promoter-independent transcription in
our original bicistronic constructs. A number of reports
have previously described promoter activity in vector
backbone sequences (19–23). To surmount this problem,
Promega Corporation recently developed the pGL4 series
of luciferase reporter vectors (24). This was done by
removing dozens of consensus transcription factor binding
sites and promoter modules. We used these redesigned
reporter vectors to create monocistronic and bicistronic
constructs carrying the p27 50-UTR. With the p27
50-UTR, monocistronic construct expression of luciferase
was  600-fold less than that driven by the SV40 promoter.
With the bicistronic constructs, expression of the down-
stream cistron was largely dependent on both the p27
50-UTR and the presence of the SV40 promoter upstream
of the ﬁrst cistron. Thus, these experiments suggest that
the sequence encoding the p27 50-UTR has very minimal
promoter activity and that the p27 50-UTR is able to
mediate cap-independent translation. This is further
supported by the observation that siRNAs targeted
to either the upstream or downstream cistron of these
pGL4-based bicistronic reporter constructs leads to
decreased expression of both cistrons.
A second potential problem associated with bicistronic
vectors is the possibility of cryptic splice sites within the
putative IRES sequence. Van Eden et al. (7) described an
RT-PCR procedure that was able to detect products from
cryptic splice sites with high sensitivity. In this report we
used a similar strategy for analyzing the transcripts
produced from the bicistronic reporter carrying the p27
50-UTR. The results provided no indication that mono-
cistronic mRNAs were produced by splicing within the
50-UTR. Further support for a lack of cryptic splicing at
sites within the p27 50-UTR was provided by experiments
in which an IRE was inserted just downstream of
the transcription start site for the bicistronic mRNA.
A splicing event involving the 50-UTR and removing
the upstream cistron (Renilla luciferase) would result
in linking the IRE to the downstream cistron
Figure 7. Eﬀect of an IRE on expression of bicistronic reporters
carrying the p27 50-UTR. Top: Diagram of potential mRNA products
resulting from transcription of a bicistronic reporter in which an IRE
has been inserted just downstream of the transcriptional start site
within the TK promoter. The top diagram shows the expected
transcript if there is no cryptic splice site within the 50-UTR. In this
case, only the upstream cistron (Renilla luciferase) would be aﬀected
by iron chelation. The bottom diagram shows the expected transcript if
the 50-UTR has a cryptic splice acceptor site. The IRE would be linked
to a monocistronic mRNA encoding only ﬁreﬂy luciferase and iron
chelation would inhibit expression of this enzyme. Bottom: NIH3T3
cells were transfected with bicistronic reporters pTKLL-472 and
pTKLL-472-IRE. These constructs are identical except that pTKLL-
472-IRE has an IRE inserted 35nt downstream of the TK transcrip-
tional start site. The transfected cells were treated with (+, gray bars)
or without ( , black bars) the iron chelator DFO. The cells were
harvested and Renilla (R) and ﬁreﬂy (F) luciferase activities were
determined. For each transfection, the value of luciferase activity in the
absence of DFO was set to 1.
4776 Nucleic Acids Research, 2007, Vol. 35, No. 14(ﬁreﬂy luciferase). If such an event was responsible for
expression of the downstream cistron then this expression
should be sensitive to treatment with iron chelators.
However, we found that only the upstream cistron was
inhibited by DFO.
Another test for IRES activity is to directly transfect
bicistronic mRNAs rather than bicistronic DNA vectors.
This approach completely avoids the processes of
transcription and splicing. However, a potential problem
with this approach is that the transfected RNAs are not
processed in the nucleus and may not have access to all of
the factors necessary to promote eﬃcient translation.
Nevertheless, we have observed signiﬁcant expression
of the downstream cistron that is dependent on the
presence of the p27 50-UTR (Figure 3). Similar RNA
transfection experiments have been carried out by Cho
et al. (13) and their results are in agreement with ours.
In addition to the results described above, several
additional ﬁndings indicate that the p27 50-UTR is able to
mediate cap-independent translation. Both Cho et al. (13)
and Shi et al. (15) have demonstrated p27 IRES-
dependent expression in a cell-free in vitro translation
system. Kullmann et al. (14) found that the presence of the
p27 50-UTR makes expression of the downstream cistron
resistant to the eﬀects of a phosphatidylinositol-3 kinase
inhibitor that represses global cap-dependent translation.
Similarly, we (12) have found that p27 IRES-driven
expression is not sensitive to the eﬀects of rapamycin
while Shi et al. (15) have actually observed an increase in
p27 IRES activity following treatment with rapamycin.
Rapamycin blocks mTOR kinase activity and speciﬁcally
inhibits cap-dependent translation because of accumula-
tion of active, hypophosphorylated 4EBP, an inhibitor of
the cap-binding protein eIF4E. Finally, we have demon-
strated that overexpression of a constitutively active
4EBP enhances cap-independent expression through the
p27 50-UTR as well as expression of the endogenous
p27 gene (17).
Finally, a highly pertinent ﬁnding was recently reported
by Yoon et al. (25). They found that cells expressing
a mutant form of the DKC1 gene had impaired translation
of p27 mRNA and other mRNAs having IRESs. DKC1
is mutated in the X-linked disease dyskeratosis congenita
which is associated with a number of abnormalities
including increased susceptibility to cancer. The DKC1
protein is a pseudouridine synthase that modiﬁes riboso-
mal RNA. Ribosomes derived from cells carrying the
DKC1 mutation have lower levels of pseudouridine and
are defective in translational initiation through cellular
and viral IRESs but show no loss in global cap-dependent
translation. Reduced expression of endogenous p27
protein and impaired ability of the p27 50-UTR to mediate
cap-independent translation, as shown by direct transfec-
tion of in vitro transcribed bicistronic mRNA, were
observed in these cells (25).
In summary, our results uncover a shortcoming in
the use of ‘promoterless’ bicistronic constructs as a means
of demonstrating cryptic promoter activity in a 50-UTR
coding sequence. They also demonstrate the importance of
using in vitro transcribed RNA as a control when mapping
putative transcription start sites by RNase protection
assays. The data presented here and other recent publica-
tions strongly support the conclusion that the p27 50-UTR
has an authentic IRES. It will be important to determine
the molecular mechanism of translation initiation through
this element, how its activity is controlled, and if it has
a role in the downregulation of p27 that is often observed
in tumor cells.
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